Trump Orders Up To 100% Tariffs On Patented Drugs
Trump signed an order threatening up to 100% tariffs on patented medicines unless companies strike pricing deals or onshore production, with negotiation deadlines for firms.
Al JazeeraTrump unveils 100 percent tariff on drugs to push for pharmaceutical deals
The GuardianAustralia says it won’t raise drug prices after Trump’s 100% tariff on pharmaceuticals imported into US
BBC NewsPharmaceuticals face 100% tariffs in US - unless they have a deal
ABC NewsTrump unveils 100% tariff on some patented drugs on 'Liberation Day' anniversary
Overview
President Donald Trump signed an executive order that could impose tariffs of up to 100% on some patented drugs from companies that do not reach deals with his administration.
In the order, Trump wrote the tariffs are necessary "to address the threatened impairment of the national security posed by imports of pharmaceuticals and pharmaceutical ingredients."
Stephen J. Ubl, CEO of PhRMA, said the taxes "on cutting-edge medicines will increase costs and could jeopardize billions in U.S. investments."
Companies that sign "most favored nation" pricing deals and build U.S. production will face a 0% tariff, while firms building U.S. projects without pricing deals will face a 20% tariff that increases to 100% in four years.
A senior administration official said larger companies will have 120 days and small and medium-sized companies will have 180 days to negotiate before the 100% tariffs take effect.
Analysis
Center-leaning sources present the tariff announcement neutrally, balancing administration claims (national security, leverage) with skeptical expert commentary and concrete details about exemptions and the UK deal. They avoid loaded adjectives, attribute assertions to officials and experts, and note potential economic and small-business impacts, yielding measured informational coverage.